In breast cancer models, it has been shown that miR-29b is induced by, and mediates the EMT-inhibitory effect of GATA3 via repression of tissue microenvironment remodelling factors such as MMP and VEGFA [68, 79]. Here, GATA3 is linked to breast cancer.